Morgan Stanley’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50,552
| Closed | -$720K | – | 8055 |
|
|
2023
Q4 | $720K | Buy |
50,552
+25,981
| +106% | +$370K | ﹤0.01% | 5458 |
|
|
2023
Q3 | $283K | Buy |
24,571
+21,501
| +700% | +$247K | ﹤0.01% | 5429 |
|
|
2023
Q2 | $50.5K | Buy |
3,070
+3,028
| +7,210% | +$49.8K | ﹤0.01% | 6209 |
|
|
2023
Q1 | $375 | Buy |
+42
| New | +$375 | ﹤0.01% | 7461 |
|
|
2022
Q2 | – | Sell |
-2,800
| Closed | -$12K | – | 8078 |
|
|
2022
Q1 | $12K | Hold |
2,800
| – | – | ﹤0.01% | 7359 |
|
|
2021
Q4 | $25K | Hold |
2,800
| – | – | ﹤0.01% | 7132 |
|
|
2021
Q3 | $38K | Buy |
+2,800
| New | +$38K | ﹤0.01% | 6836 |
|